Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Manpenkang enema for chronic pelvic pain after pelvic inflammatory disease
CTR20140224Phase 3Active
- Sponsor
- Shaanxi Jingwei Pharmaceutical
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Manpenkang in chronic prostatitis (CP), Pelviabdominal infection, sponsored by Shaanxi Jingwei Pharmaceutical. Started May 2014; status: active.
02
Drugs
Manpenkang
03
Conditions
chronic prostatitis (CP)Pelviabdominal infection
Beyond the preview
Go deeper on CTR20140224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140224.